Skip to content
Home / News |

Barclays Adjusts Exchange Stocks – Winners and Losers (CBOE, NDAQ, TW, MRX, CME, MKTX)

Cboe Global Markets saw its price target increased by Barclays, signaling a positive outlook ahead of its third-quarter earnings report. The adjustment reflects confidence in the exchange operator’s performance amid fluctuating market conditions.

Barclays analyst Benjamin Budish raised the firm’s price target on Cboe to $264 from $256, maintaining an “Equal Weight” rating. This decision comes as the exchange sector braces for the release of Q3 financial results. The adjustment indicates a cautiously optimistic outlook, acknowledging Cboe’s steady performance in the options and futures markets.

Volumes across the futures segment experienced quarter-over-quarter growth despite lower volatility, while the options market saw “nice growth,” according to the analyst’s research note.

WELCOME BONUS - Free Share Bundle When You Invest £50! Open a UK Investment Account: Shares, ISAs, Managed Portfolio Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply. IG
5.0
View Offers
Empfohlener Broker Multi Asset Platform
Social-Trading-Pionier mit Aktien, ETFs, Krypto und CFDs, Copy Trading inklusive. eToro
5.0
Weitere Informationen 50% of retail investor accounts lose money when trading CFDs with this provider.

The increase suggests confidence in Cboe’s ability to navigate the current market environment effectively. This contrasts with price target decreases for several competitors.

The options market remains a key strength for Cboe, contributing significantly to its revenue streams. Despite broader market uncertainties, Cboe’s ability to generate volume growth in both futures and options suggests a resilient business model. The “Equal Weight” rating implies that Barclays believes Cboe’s stock is fairly valued relative to its peers and the broader market.

While Barclays does not anticipate significant surprises in the Q3 reports, the revised price target for Cboe signals a recognition of its stable performance. Market participants will be closely watching the actual earnings release to assess whether Cboe can maintain its growth trajectory.

The reassessment of Cboe’s price target by Barclays, in contrast to lowered targets for its competitors, underlines its perceived strength in the exchange sector.

Lowered, Bullish

  • Nasdaq (NASDAQ: NDAQ) trimmed to $108 from $109, with an Overweight rating.
  • Tradeweb Markets (NASDAQ: TW) cut to $144 from $170, Overweight rating held.
  • Marex Group stock (NASDAQ: MRX) lowered to $40 from $50, with Overweight rating maintained.

Lowered, Neutral

  • CME Group (NASDAQ:CME) lowered to $280 from $298, Equal Weight rating.
  • MarketAxess (NASDAQ: MKTX) cut to $186 from $200, maintaining Equal Weight.

Cboe Global Markets heads into its Q3 earnings report with a positive signal from Barclays, which raised its price target to $264 based on strong volume growth in key segments. While the “Equal Weight” rating suggests the stock is currently seen as fairly valued, Cboe’s ability to outperform competitors highlights its resilient business model. Investors will be watching the upcoming earnings to confirm if this growth trajectory can be sustained.

Searching for the Perfect Broker?

Supplement your charting with a free trading platform that rivals the best out there – multiple charts on one screen for easy monitoring, ProRealTime provides the perfect support for your investing or trading journey.

Discover our top-recommended brokers for trading stocks, forex, cryptos, and beyond. Dive in and test their capabilities with complimentary demo accounts today!

YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY